Panayiotis M.
- Country
- Greece
- Department
- Neurology Department
Research Overview
- Efficacy and Safety of Intravenous Tenecteplase versus Standard of Care in Patients with Acute Ischemic Stroke Presenting >4.5 Hours from Last Known Well with Salvageable Tissue
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Randomized, Quadruple-Blind, Placebo-Controlled Phase 2b Study of Batoclimab in Adults with Active Chronic Inflammatory Demyelinating Polyneuropathy
Data & Insights
Has run more than one trial at 83 of 334 partner sites.
Specializations
Inflammatory Bowel Disease
The investigator is involved in clinical research on Crohn’s disease and ulcerative colitis, with interest in therapies for persistent intestinal inflammation, symptom control, and long-term disease management.
- Crohn’s disease
- Ulcerative colitis
- Inflammatory bowel disease
Research activity in this area also extends to treatment strategies for fistulizing perianal Crohn’s disease and moderately to severely active disease.
Autoimmune and Systemic Rheumatic Disease
Clinical trial involvement includes systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis, reflecting a strong therapeutic focus on immune-mediated joint and connective tissue disorders.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Psoriatic arthritis
- Axial spondyloarthritis
Additional interest is seen in systemic sclerosis and broader autoimmune diseases requiring targeted immunomodulatory treatment.
Pulmonary and Respiratory Disorders
The investigator participates in studies of pulmonary sarcoidosis, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and chronic obstructive pulmonary disease.
- Pulmonary sarcoidosis
- Idiopathic pulmonary fibrosis
- Progressive pulmonary fibrosis
- Chronic obstructive pulmonary disease
Therapeutic interest also includes severe respiratory infection settings such as hospital-acquired pneumonia and severe community-acquired bacterial pneumonia.
Kidney and Complement-Mediated Disease
Research activity covers IgA nephropathy, idiopathic immune complex membranoproliferative glomerulonephritis, complement 3 glomerulopathy, and other proteinuric kidney diseases.
- IgA nephropathy
- Complement 3 glomerulopathy
- Idiopathic immune complex membranoproliferative glomerulonephritis
- Chronic kidney disease
There is also involvement in therapies for chronic kidney disease with associated inflammation and proteinuria.
Neurologic, Vascular, and Neuroinflammatory Conditions
Within the Department of Neurology, the investigator is engaged in studies of acute ischemic stroke, stroke prevention, atrial fibrillation, sepsis, and chronic inflammatory demyelinating polyneuropathy.
- Acute ischemic stroke
- Stroke prevention
- Atrial fibrillation
- Chronic inflammatory demyelinating polyneuropathy
Additional therapeutic interests include sepsis and neurologic immune-mediated disease linked to inflammatory and vascular risk.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.